Latest news with #ITA
The Hindu
3 days ago
- Health
- The Hindu
Telangana man dies of ill-health in Israel
A 57-year-old native of Jagtial town in Telangana died of ill-health in Tel Aviv on Monday. Representatives of the Israel Telangana Association confirmed the passing away of Revella Ravinder on Monday and pointed out that the deceased had been ailing for the past few months due to heart-related ailments. He was admitted to hospital three weeks ago and died while undergoing treatment earlier this week, the representatives said, adding that the body has been preserved in mortuary. 'All related formalities have been completed and the Indian Embassy in Tel Aviv has been informed about the death of the individual,' the ITA office-bearer said. The ITA leader said since flight operations were completely stopped, it was uncertain when the mortal remains would be sent to India. The ITA also denied reports that the deceased had died of suffocation after taking shelter in a bunker after sirens blared during the missile attack on Tel Aviv.
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
Growers welcome Centre's move to include tea in weather insurance scheme
Tea growers hailed the government's decision to bring the sector under the Restructured Weather Based Crop Insurance Scheme (RWBCIS), which they said would help mitigate losses due to erratic rainfall and rising temperatures. The Department of Agriculture and Farmers Welfare issued a notification on June 10, stating that the insurance scheme would come into effect from the Kharif 2025. States and UTs were asked to expedite the floating of tenders, finalisation of the insurance company and other modalities by June 20 to ensure that farmers can avail the benefit of the scheme. Indian Tea Association (ITA) secretary general Arijit Raha told PTI this is the first time the sector has been brought under the purview of a weather-based insurance scheme. "The tea sector is witnessing frequent fluctuations in production due to erratic rainfall, waterlogging and a rise in temperature, exceeding 35 degrees Celsius. Climate change adaptation and mitigation have become a major challenge to keep the sector sustainable," he said. "In this context, a weather-based crop insurance is a necessity. We heartily welcome the decision of the Centre to extend the scheme to this sector," he added. Confederation of Indian Small Tea Growers (CISTA) president Bijoy Gopal Chakraborty said the demand for it was being raised for the last five years. "We welcome this step. Crop insurance is an effective and mitigating component in the backdrop of climate change. Tea cultivation by small growers had been hit by high temperatures and excessive rains," he said. India, the second-largest tea producer in the world after China, reported 1,382 million kg of production in 2024. In 2023, it produced 1,375 million kg of tea. Small tea growers contribute to more than 50 per cent of the country's total production. Assam is the largest tea-producing state in the country, followed by West Bengal and the southern states of Tamil Nadu, Karnataka and Kerala. Tripura, Arunachal Pradesh, Sikkim, Himachal Pradesh, and UP are among the states that grow small quantities of tea. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Yahoo
13-06-2025
- Business
- Yahoo
Sector ETFs Likely to Gain Amid Israel-Iran Tensions
Israel launched a surprise attack on Iran on June 12, triggering global market turmoil. The Israeli government described the assault as a "preemptive strike" against what it claimed was Iran's advancing nuclear weapons program. Explosions were reported across Tehran following the attack. In response to the escalating tensions, Israel's defense minister declared a state of emergency and said the country was preparing for possible retaliation from Iran. Meanwhile, U.S. Secretary of State Marco Rubio confirmed the United States was not involved in the strikes and cautioned Iran against targeting American assets or personnel. Against this backdrop, below we highlight a few sector-based exchange-traded funds (ETFs) that could gain higher. Energy – Energy Select Sector SPDR ETF XLE The conflict immediately jolted commodity markets. Crude oil surged about 5% (at the time of writing), reflecting investor fears over supply disruptions from Iran, OPEC+'s third-largest producer. Energy ETFs like XLE should gain higher amid this kind of scenario. Gold Mining – Themes Gold Miners ETF AUMI Safe-haven demand also spiked, pushing gold up about 1%. Since mining stocks often act as a leveraged play of the underlying metal, AUMI should gain higher. The underlying Solactive Global Pure Gold Miners Index provides exposure to companies that are active in the gold mining industry and is denominated in U.S. dollars. Gold-mining margins are at a 50-year high, according to analysts, as quoted on Wall Street Journal. Defense – iShares U.S. Aerospace & Defense ETF ITA Investors may turn to defense ETFs during heightened Israel-Iran tensions as geopolitical conflicts often lead to increased military spending and defense readiness. Companies in these ETFs—such as those producing weapons, surveillance systems, or military technology—stand to benefit from rising demand. As a result, defense ETFs like ITA come across as a strategic hedge (read: Guide to Aerospace & Defense ETFs). Cybersecurity – ETFMG Prime Cyber Security ETF HACK Modern warfare includes cyber threats, increasing demand for digital security. During periods of heightened tension, governments and corporations may face elevated risks of cyberattacks targeting critical infrastructure, defense systems, financial institutions, and communication the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Energy Select Sector SPDR ETF (XLE): ETF Research Reports Amplify Cybersecurity ETF (HACK): ETF Research Reports iShares U.S. Aerospace & Defense ETF (ITA): ETF Research Reports Themes Gold Miners ETF (AUMI): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
France 24
11-06-2025
- Sport
- France 24
How have teams qualified for the Club World Cup?
With 12 representatives, Europe is sending more teams than any other continent, followed by South America with six. Asia and Africa both have four competing teams, as does the CONCACAF region of North and Central America and the Caribbean. In addition, there is one club from Oceania while the line-up is completed by a representative from the host nation. There are two ways of qualifying for the tournament, which football's world governing body now intends to stage every four years -- either as continental champions or via a club ranking based on performances in continental competitions over a four-year period. Continental champions The following 16 teams qualified as continental champions over the period from 2021 to 2024: UEFA Champions League winners: Chelsea (ENG/2021), Real Madrid (ESP/2022 and 2024), Manchester City (ENG/2023) Copa Libertadores winners: Palmeiras (BRA/2021), Flamengo (BRA/2022), Fluminense (BRA/2023), Botafogo (BRA/2024) AFC Champions League winners: Al Hilal (KSA/2021), Urawa Red Diamonds (JPN/2022), Al Ain (UAE/2023 and 2024) CONCACAF Champions League winners: Monterrey (MEX/2021), Seattle Sounders (USA/2022), Pachuca (MEX/2024) CAF Champions League winners: Al Ahly (EGY/2021, 2023 and 2024), Wydad Casablanca (MAR/2022) OFC Champions League winners: Auckland City (NZL/2022, 2023 and 2024) Best four-year rankings The following 14 teams qualified via their performances in continental club competitions over the last four years: Europe: Bayern Munich (GER), Paris Saint-Germain (FRA), Borussia Dortmund (GER), Inter Milan (ITA), Porto (POR), Atletico Madrid (ESP), Benfica (POR), Juventus (ITA), Red Bull Salzburg (AUT) South America: River Plate (ARG), Boca Juniors (ARG) Asia: Ulsan HD (KOR) Africa: Esperance (TUN), Mamelodi Sundowns (RSA) Host representatives That leaves two berths, both of which have gone to teams who will be playing on home turf. Perhaps conveniently for FIFA as they look to get eyeballs on their new competition, Lionel Messi's Inter Miami are the designated representatives of the host nation. That is after they won the Supporters Shield for being the best performing side during the 2024 MLS regular season -- even though LA Galaxy went on to win the MLS Cup to determine the overall champions. Los Angeles FC claimed the last spot with a 2-1 extra-time victory against Club America of Mexico in a play-in match at the end of last month. The spot became available following FIFA's decision to ban Mexican club Leon from the tournament. Leon were barred because the club is owned by Grupo Pachuca, which also controls Liga MX side Pachuca, who are also taking part. LAFC were given the chance on the basis of finishing as runners-up to Leon in the 2023 CONCACAF Champions League.
Cision Canada
10-06-2025
- Business
- Cision Canada
Spiderwort Biotechnologies Inc. Receives Health Canada Investigational Testing Authorization for Next-Generation Dermal Filler
® represents the next-generation in medical aesthetics leveraging Spiderwort Biotechnologies regenerative cellulose-based technology platform OTTAWA, ON, June 10, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced it has received Investigational Testing Authorization (ITA) from Health Canada for CelluJuve ®, its next-generation cellulose-based dermal filler currently under development. The ITA enables Spiderwort Biotechnologies Inc. to initiate a human clinical trial in Canada to evaluate the safety and performance of CelluJuve ® for tissue augmentation and rejuvenation. The planned clinical trials will evaluate the interaction between CelluJuve® and human tissues. This authorization follows the company's successful completion of ISO 10993 biocompatibility testing and human skin safety testing for CelluJuve ®. "Receiving the Investigational Testing Authorization from Health Canada is a critical inflection point in our mission to transform the landscape of regenerative medicine in multiple categories," said Dr. Charles M. Cuerrier, CEO of Spiderwort Biotechnologies Inc."This achievement validates our rigorous development approach and accelerates our path toward bringing CelluJuve ® to patients and clinicians who are seeking innovative alternatives in dermal fillers. We're excited to begin the clinical evaluation phase and demonstrate the potential benefits of our cellulose-based technology Aerocel™ in medical aesthetics and beyond." "As a board certified dermatologist with extensive experience in facial aesthetics, I am encouraged by CelluJuve®'s innovative approach to tissue augmentation." Dr. Joely Kaufman, MD, FAAD, member of Spiderwort's Clinical Advisory Board, "The preliminary data suggests that this cellulose-based technology could potentially offer an alternative method to address the signs of facial aging. I look forward to seeing the clinical results of this promising biomaterial." CelluJuve ® is under development to provide medical professionals with a cellulose-based alternative to current dermal fillers. The product is designed to work with the body to create a natural look and feel by providing a framework for collagen deposition, with the initial target for Spiderwort Biotechnologies Inc.'s research being nasolabial fold remediation. The company's state-of-the-art ISO 5 cleanroom facility, announced earlier this year, will support the production of medical-grade CelluJuve ® for the upcoming trials, ensuring all materials meet the quality standards required for human use. "CelluJuve® is a testament to where bold science can lead," said Dr. Andrew Pelling, Chief Science Officer at Spiderwort Biotechnologies Inc."We're demonstrating how plant-derived biomaterials can become a powerful foundation to address a variety of medical needs. These recent and critical regulatory advancements in our product portfolio reveal how nature inspired innovation can unlock entirely new frontiers in rejuvenating and regenerating human tissues." CelluJuve ® is a device under development. While it has received Investigational Testing Authorization from Health Canada for clinical trials, it is not yet approved by Health Canada or the U.S. Food and Drug Administration (FDA) for commercial use, and it is not available for sale. The safety and effectiveness of CelluJuve ® in humans has not been fully established and will be evaluated in upcoming clinical trials. For more information about Spiderwort Biotechnologies and CelluJuve ®, please visit About Spiderwort Biotechnologies Inc. Spiderwort is transforming biotechnology with a platform of cellulose-based biomaterials that serve as the scaffolds for the regenerative medicine of the future. Spiderwort's biomaterials have shown promise in the treatment of spinal cord injuries and soft tissue regeneration. Spun out as a startup from the Pelling Lab, Spiderwort is led by CEO Charles M. Cuerrier and inspired by the work of CSO and TED Fellow Andrew E. Pelling. Learn more at
